Research Article
Clinical End-Points Associated with Mycobacterium
tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution
Table 1
Patient characteristics.
| | Characteristic | Values | Lung cancer | TB, non-lung-cancer | Non-TB, non-lung-cancer |
| | Eligible patients | Total number | 187 | 31 | 39 |
| Category
WHO (lung cancer histological classification) of 2004 | Squamous cell carcinoma (SCC) | 63 | NA | NA | | Lung adenocarcinoma (LAC) | 77 | NA | NA | | Bronchioloalveolar carcinoma (BAC) | 27 | NA | NA | | Small cell lung carcinoma (SCLC) | 20 | NA | NA |
| | Clinical stage (UCC 1997) | I, II | 61 | NA | NA | | III, IV | 70 | NA | NA |
| | Tumor size |
≤3 cm | 56 | NA | NA | | >3 cm | 75 | NA | NA |
| | Lymph node metastasis | Yes | 89 | NA | NA | | No | 42 | NA | NA |
| | History of TB | Yes | 19 | 31 | NA | | No | 112 | 0 | NA |
| | Gender | Male | 80 | 26 | 14 | | Female | 107 | 5 | 27 |
| | Pathology grade | I | 22 | NA | NA | | II | 60 | NA | NA | | III | 63 | NA | NA |
| | Age | | 59.3 (mean), 10.3 (sd) | 53.4 (mean), 9.1 (sd) | 49.9 (mean), 7.6 (sd) |
|
|
